• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Interferon alpha-21 (IFNA21)

ACP03871

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP03871 Target NameIFNA21
Target SynonymsIFNA21; Interferon alpha-21; IFN-alpha-21; Interferon alpha-F; LeIF FFormLiquid or Lyophilized powder
Expression SystemYeastExpression Range24-189aa
Mol Weight21.3kDaProtein LengthFull Length of Mature Protein
PurityGreater than 90% as determined by SDS-PAGE.Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDP01568
Background Information
  • Uniprot Id

    P01568

  • Target Species

    Human

  • Target Name

    IFNA21

  • Target Full Name

    Interferon alpha-21

  • Target Function

    Produced by macrophages, IFN-alpha have antiviral activities. Interferon stimulates the production of two enzymes: a protein kinase and an oligoadenylate synthetase.

  • Target Subcellular Location

    Secreted.

  • Target Protein Families

    Alpha/beta interferon family

  • Target Research Area

    Immunology

  • Target Synonyms

    IFNA21; Interferon alpha-21; IFN-alpha-21; Interferon alpha-F; LeIF F

  • Target Background

    This gene is a member of the alpha interferon gene cluster on the short arm of chromosome 9. Interferons are cytokines produced in response to viral infection that mediate the immune response and interfere with viral replication. The encoded protein is a type I interferon and may play a specific role in the antiviral response to rubella virus.

Inquire Recombinant Human Interferon alpha-21 (IFNA21) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification